Aims: To describe the demographics of the paediatric RRT population under the age of 16 years in the UK and to analyse changes in demography with time. Methods: Data were collected from all 13 paediatric renal centres within the UK. A series of cross-sectional and longitudinal analyses were performed to describe the demographics of paediatric RRT patients. Results: A total of 856 children and young people under 18 with ERF were receiving treatment at paediatric nephrology centres in 2011. At the census date, 80.1% had a functioning transplant, 10.5% were receiving peritoneal dialysis (PD) and 9.4% were receiving haemodialysis (HD). In patients aged <16 years the prevalence of ERF was 56.8 pmarp and the incidence 8.3 pmarp. Analysis of trends over the last 15 years shows that both incidence and prevalence are increasing. A third of the prevalent patients had one or more reported comorbidities. At transfer to adult services, 86% of patients had a functioning renal transplant. Pre-emptive transplantation was seen to occur in 31% of children starting RRT under 16 years, with lower rates seen in girls and ethnic minorities. Survival in childhood amongst children starting RRT was the lowest in those aged less than 2 years. Conclusions: The data provided in this report show increasing trends over 15 years in the incidence and prevalence of established renal failure. This is important for the planning of the provision of care for children needing renal replacement therapy. Further research is required to understand the gender and ethnic differences in pre-emptive transplantation rates and the reduced survival amongst children aged less than 2 years.
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Introduction
Established renal failure (ERF) requiring renal replacement therapy (RRT) is a rare but significant cause of long term morbidity and mortality during childhood, with specialist care being provided in 13 paediatric nephrology centres in the UK. All centres are equipped to provide peritoneal dialysis and haemodialysis, with ten centres also undertaking kidney transplantation for children. In the United Kingdom (UK), prevalence rates of treated ERF in children aged under 16 have risen steadily over the last 15 years to 59.3 per million age related population (pmarp) in 2010 [1] . Incidence rates for ERF have also shown an increasing trend during this time period rising to 8.1 pmarp in 2010 [1] .
The objectives of this report are:
(i) To describe the UK prevalence, incidence, causes of ERF and modality of treatment of children on RRT on 31st December 2011 (ii) To describe trends of the same over the past 15 years, and (iii) To describe pre-emptive transplantation rates and survival of children on RRT aged <16 years old in the UK.
Methods
Data collection was performed by all 13 paediatric nephrology centres managing children on RRT in the UK in 2011. Most centres submitted data electronically to the UK Renal Registry (UKRR) with only four centres submitting data using paperbased data returns this year. These data items were then manually entered into the current paediatric UKRR database. Southampton was only able to provide a limited electronic dataset due to recent implementation of a bespoke renal IT system.
In this report, patient groups are described as: (i) 'prevalent' group: patients who were receiving RRT on the 31st December 2011; (ii) 'incident' group: patients who started RRT between 1st January and 31st December 2011; and (iii) '5 year' groups: patients who started RRT in the periods of 1997-2001, 2002-2006 and 2007-2011 .
The populations used to calculate the incidence and prevalence rates were obtained from the Office for National Statistics (ONS) [2] . The mid-2011 population estimate produced by the ONS, based on the 2011 Census, was used for calculating the 2011 incident and prevalent group rates; the 2001 Census data was used for the 1997-2001, 2002-2006 and 2007-2011 '5 year' groups.
Infants under the age of 3 months and 'late presenters' (defined as children commencing dialysis within three months following review by a paediatric nephrologist) were excluded from analyses when calculating pre-emptive transplantation rates. For survival analysis, only patients starting RRT between 1st January 1997 and 31st December 2010 were included to ensure a minimum of 1 year follow up at the date of census, 31st December 2011, and were followed up to a maximum age of 16 years.
Statistical analyses
Statistical analyses were performed using SAS 9.3, with group analyses using Chi-square test and median analyses using KruskalWallis test. A Cox regression model was used in calculating hazard ratios for patient survival, adjusting for gender, age at start of RRT, and RRT modality as a time dependent variable. Survival probabilities were calculated using univariate Kaplan Meier curves.
Results
Accuracy and completeness of data returns Significant efforts to improve the overall accuracy of the entire paediatric dataset by clinical teams, data managers and statisticians have continued this year, resulting in improved accuracy of the database, analyses and conclusions. As for data returns, the procedures for data collection and processing are still evolving but are yielding consistent results, now with near 100% data completeness achieved by all centres for a range of data items including, gender, ethnicity, treatment modality at start of RRT and age at start of RRT. Data completeness for other core items was better than previous reports and is shown in table 4.1 [1] .
The UK paediatric prevalent ERF population in 2011 A total of 856 children and young people under 18 years with ERF were receiving treatment at paediatric nephrology centres in 2011. At the census date, 80.1% had a functioning kidney transplant, 10.5% were receiving peritoneal dialysis (PD) and 9.4% were receiving haemodialysis (HD).
Patients aged 16-18 years may receive their medical care either in a paediatric or in an adult nephrology centre. As data were incomplete for the 16-18 year old adolescent patients they have been excluded from the majority of subsequent analyses (particularly when describing incidence and prevalence rates). This report therefore presents data largely relating to patients less than 16 years of age.
There were 675 children under 16 years of age receiving RRT in the UK in 2011. Table 4 .2 shows the number of patients receiving RRT by age group and gender plus rate of RRT pmarp. The prevalence of RRT increased with age and was higher in males across all age groups with an overall male to female prevalence ratio of 1.5. The reported prevalence rate in under 16 year olds was 56.8 pmarp. Modality of treatment Current treatment modality in the prevalent paediatric population less than 16 years old in 2011 is displayed in figure 4.1. Of the 79% with a functioning transplant, 54% received deceased donor transplantations.
The treatment modality in use at the start of RRT is displayed in figure 4.2. This shows that 48% of patients were treated with PD at the start of RRT whilst 28% of patients were treated with HD. Twenty-four percent of children under 16 were reported to have received a pre-emptive transplant.
Further treatment modality analysis by age is shown in table 4.4 which demonstrates that in the under 2 year olds the majority of patients were being treated with PD (63.2%). This contrasts with older children in the 12 to 15.99 year age group where 85.9% had a functioning graft and where similar proportions were on HD and PD. Subsequent analysis of RRT modality by gender and ethnicity showed no difference. However as absolute sub-group numbers are small, caution is needed in conducting any comparative analyses. Table 4 .5 and figure 4.3 show the diagnostic categories for the prevalent ERF population under 16 years in 2011. There has been a marked improvement in data completeness in this category over the last few years with missing data falling to only 0.4% from 2.9% in the 2010 report [1] . Of the 675 patients, renal dysplasia AE reflux remained the commonest condition causing ERF (32.3%), whilst there were no documented patients with drug nephrotoxicity.
Cause of ERF
As for associated comorbidities at the onset of RRT, table 4.6 shows that congenital abnormalities were the commonest, reported in 9.2%, whilst both developmental delay and syndromic diagnoses each were reported in over 6% of patients. Prematurity was also frequently reported (7.1%), whilst neural tube defects were least common in 0.3% of patients. Overall 68.9% of patients had no registered comorbidities, with 20.4% having one comorbidity listed, and 10.7% having two or more comorbidities. Centre analysis showed significant variation in reporting of registered co-morbidities, with some centres, Birmingham (88%), Glasgow (83%), GOSH (80%) and Cardiff (80%) reporting no comorbidity in the majority of their patients, as compared to other centres which reported no comorbidity in a smaller proportion of patients, Bristol (43%) and Leeds (45%).
The UK incident paediatric ERF population in 2011
There were 114 patients under 18 years of age who commenced RRT at paediatric renal centres in 2011. As previously, the following analyses are restricted to the 99 patients who were under 16 years of age.
The incidence rate of RRT was 8.3 pmarp in 2011. Patients commencing RRT in 2011 are displayed by age and gender in table 4.7. Table 4 .8 shows that the reported incidence of RRT has been rising since 1997, with the highest incidence rates seen in the 12-15.99 year age group, with the 0-1.99 year age group having the next highest rates. Table 4 .12 shows the number and percentage of children receiving RRT with each of the major reported comorbidities over the last 15 years. Whilst congenital abnormalities (6.9%), developmental delay (6.2%) and syndromic diagnoses (6.4%) were the most common reported comorbidities in 2007-2011, there has been little change in the percentage of children receiving RRT with a reported comorbidity over the last 15 years.
As for changes in modality at the start of RRT, figure 4.4 shows that the percentage of children who were using PD at the start of RRT has fallen from 51. 
Pre-emptive transplantation
Of a total of 1,656 patients who started RRT between 1997-2011, 448 patients were excluded from analysis (93 patients were excluded due to being aged <3 months, and a further 355 patients were excluded due to being 'late presenters'). Of 1,208 patients identified as being aged 3 months to <16 years and having started RRT between 1997-201l, pre-emptive transplantation was seen to occur in 30.6% of patients and was significantly higher in males (33.6%) than females (25.8%), p ¼ 0.004 (table 4.14). Ethnicity was also seen to be a significant factor, with children from Black (12.1%) and South Asian (18%) ethnicity having significantly lower rates of transplantation than their White counterparts (33.6%), p < 0.0001. Analysis by age at start of RRT showed that as expected, the lowest rate of pre-emptive transplantation was in the 3 months to 2 year group (6.8%), whilst children aged 4 to 16 years had similar rates of pre-emptive transplantation. As for PRD, children with obstructive uropathy (43.2%), polycystic kidney disease (41%) and renal dysplasia AE reflux (40.6%) had the highest rates of pre-emptive transplantation, whilst those with congenital nephrotic syndrome (5.2%) and glomerular disease (11.7%) had the lowest rates Transfer of patients to adult renal services in 2011 A total of 93 patients were reported by paediatric nephrology centres to have been transferred to adult renal services in 2011. The median age of patients transferred out was 18.0 years with an inter-quartile range of 17.5 years to 18.8 years. Manchester, Leeds and Bristol had the largest numbers of adolescents transferred to adult services in 2011. Table 4 .15 shows that of the transferred patients 65.6% were male, with ethnic minorities constituting 11.1% of patients. The vast majority (86%) had a functioning renal transplant at the time of transfer to an adult renal centre. Renal dysplasia AE reflux was the primary renal diagnosis in over a third of patients.
Survival of children on RRT during childhood
Of patients under the age of 16, 1,551 were identified as starting RRT between 1997 and 2010 at paediatric centres in the UK and were included in the survival analyses. At the census date (31st December 2011) there were a total of 104 deaths within the cohort on RRT at age <16, with a median follow up time of 3.4 years (range of 1 day to 15 years). Table 4 .16 shows the survival hazard ratios after adjustment for age at start of RRT, gender and RRT modality, and highlights that children starting RRT at 0-1.99 years have the worst survival outcomes with a hazard ratio of 5.13 (CI 2.62-10.03, p < 0.0001) when compared to 12-16 years olds. Outcomes in the 2-3.99 age group were also significantly lower with a hazard ratio of 2.69 (CI 1.2-6.02, p ¼ 0.02). Gender was not seen to have any impact on survival although being on dialysis as expected was seen to lower survival significantly compared to having a functioning transplant with a hazard ratio of 6.04 (3.28-11.15, p < 0.0001). Figure 4 .5 shows unadjusted Kaplan Meier survival probabilities. As the maximum age of follow up was restricted to 16 years, it was not possible to calculate 10 year survival probabilities for patients starting RRT aged >8 years, or 5 year survival probability for children starting RRT aged >12 years. This figure again highlights worse outcomes for those aged 0-1.99 years.
Mortality data in 2011
There were nine deaths in renal paediatric centres in 2011. The reported mortality of children with treated ERF in 2011 in the UK at paediatric centres was 1.3% (9/675). The median age at death was 7.8 years with a range of 1.7 years to 16.9 years. Sepsis was cited as a cause of death in four patients, two of which were associated with peritonitis and one due to bowel 
Data completeness
The ongoing sustained effort to improve data accuracy must continue and the aim to move to full electronic annual returns from all centres remains. A revised data set (The NEW Paediatric Dataset) will be used for future registry returns. These ongoing efforts to improve the quality and consistency of the data received will be rewarded by enabling enhanced interpretation of centre specific measures of clinical performance.
Incidence, prevalence and trends The incidence rate of RRT in the less than 16 year age group was 8.3 pmarp in 2011; this rate has been rising since 1997. The overall prevalence rate of RRT in the less than 16 year age group was 56.8 pmarp. The prevalence of RRT increased with age and was higher in males across all age groups. The number of children receiving RRT also continued to rise particularly in the under 2-year age group. Overall, there was a continuing trend of increased prevalence of children on RRT with increased age, in keeping with improved survival with increasing age. This coupled with an increase in the number of children receiving RRT over the past 15 years has led to a steady increase in the prevalent ERF population.
Treatment modality of ERF and observed trends 1997-2011
Peritoneal dialysis was the initial treatment modality for 48% of children at the start of treatment, 28% commenced HD and 24% received a pre-emptive transplant. Age influenced the modality of RRT with the majority of the under 2's (63%) receiving PD. Overall the majority of prevalent children (79%) on RRT had a functioning transplant.
Pre-emptive transplantation Pre-emptive transplantation was seen to occur in 30% of children under 16 years age. The rate of pre-emptive transplantation has increased over the past 15 years (26.0% in 1997-2001 to 33% in 2007-2011). There were significantly lower rates of pre-emptive transplantation in girls and ethnic minorities and further detailed studies investigating these would be important.
Comorbidities
At the onset of RRT, 31% of patients had 1 or more associated comorbidity. This overall percentage has remained similar over the past 15 years. Of note is the significant variation in registered comorbidity rate between centres (43% to 88%, data not shown); it is likely that this is influenced by different reporting practices between centres. It is hoped that the recently agreed NEW Paediatric Dataset will help improve consistency and reliability of data submission thus improving report accuracy.
Causes of ERF and observed trends 1997-2011
As previously, renal dysplasia AE reflux (30%), glomerular disease (20%) and obstructive uropathy (16%) were the commonest listed aetiologies for children with ERF. These accounted for 66% of all patients for whom a primary diagnosis had been reported. Observation of trends over the 15-year period showed an increase in the percentage of children receiving RRT with unknown aetiology.
Transfer out and survival data Data relating to transfer to adult renal services is included in the current report. The median age of transfer was 18.0 years. Of patients receiving RRT, 86% transferred with a functioning renal transplant. There appears to be variation in practice between centres regarding transition and transfer out arrangements; it is also likely that variability exists in reporting of 'transfer out' timelines to the registry for patients being transitioned to adult centres. Consensus regarding terminology will facilitate future comparative interpretation.
Survival data of children on ERF during childhood who commenced RRT between 1997 and 2010 highlights the less favourable outcome for children less than 2 years of age. Longer term survival data up to 5 years was available for those <12 years and 10 year survival data for those <8 years only. For the majority of children on RRT long term survival data will need follow up in to young adulthood. This is the focus of an ongoing project of the UK Renal Registry.
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